Amazon fails to cancel FTC subpoenas for Bezos, Jassy testimony

Date:

Amazon.com founder Jeff Bezos and Chief Executive Andy Jassy won’t be able to avoid testifying in an investigation related to the company’s Prime membership program.

The Federal Trade Commission (FTC) made that announcement late Wednesday, according to The Wall Street Journal.

The FTC is investigating the company’s policies concerning its Prime sign-up and cancelation process.

Amazon asked the FTC last month to cancel the subpoenas for Bezos and Jassy saying they aren’t steeped in the details of those processes.

FTC LOOKING INTO AMAZON’S $1.7B DEAL FOR IROBOT

The FTC’s staff started the probe in March 2021, looking at whether the company didn’t provide a simple way for customers to cancel the program’s recurring charges, according to the order issued Wednesday.

The FTC said Amazon must largely comply with a June investigative demand that sought information about other Amazon subscription programs, but Amazon pushed back saying the request was too burdensome and expansive.

Amazon's Andy Jassy speaking while wearing a suit jacket

FTC WANTS MORE INFORMATION ON AMAZON’S ONE MEDICAL PURCHASE

A spokesman for Amazon said the company cooperated with the FTC investigation and already produced tens of thousands of pages of documents.

Logo of Amazon Prime

“We remain concerned that the latest requests are overly broad and needlessly burdensome, and we will explore all our options,” the spokesman said.

Read the full article here

spot_img

Share post:

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Popular

More like this
Related

San Diego police officer shot, sparking manhunt for ‘armed and dangerous’ suspect

A San Diego police officer was shot Thursday afternoon,...

Stock Market News: GameStop shares slump, S&P 500 enters bull market, Tesla’s winning streak

Breaking NewsS&P exits bear marketThe S&P 500 entered a...

Heart disease: Experimental cancer drug may slow inflammation from atherosclerosis

The medication saracatinib has been researched in the past...

Do you believe in Gun Rights?

150,000 Subscribers Already Enjoy our High Caliber News & Gear.

Join Today And Subscribe Now